Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

38.26 USD +0.91 (+2.45%)
Streaming Delayed Price Updated: 12:32 PM EDT, Sep 28, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,339,121
Open 38.07
Bid (Size) 38.25 (9)
Ask (Size) 38.26 (2)
Prev. Close 37.34
Today's Range 37.98 - 38.43
52wk Range 24.10 - 46.62
Shares Outstanding 1,379,810,502
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Boston Scientific Launches ACURATE neo2™ Aortic Valve System in Europe
Next-generation Valve Designed to Reduce Paravalvular Leaking, Improve Procedural Efficiency and Treat More Patients with Expanded Indication over Prior Version 
From PR Newswire
Boston Scientific Announces Expanded Investment and Exclusive Acquisition Option Agreement with Farapulse, Inc.
Agreement expands company's access to pulsed field ablation technology 
From PR Newswire

Performance

YTD
-15.61%
-15.61%
1 Month
-6.76%
-6.76%
3 Month
+10.40%
+10.40%
6 Month
+20.91%
+20.91%
1 Year
-5.98%
-5.98%

More News

Read More
Boston Scientific Launches Vercise Genus™ DBS System In Europe
From PR Newswire
CMS Grants Additional Reimbursement For The Eluvia™ Drug-Eluting Vascular Stent System
From PR Newswire
Global Electrophysiology Devices Market Could Exceed $12.2 Billion By 2026
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Electrophysiology Devices Market Could Exceed $12.2 Billion By 2026
From PR Newswire
Boston Scientific Announces September 2020 Conference Schedule
From PR Newswire
Global Pain Management Devices Market Could Exceed $9 Billion By 2026
Tags Featured News
From FinancialNewsMedia.com Newswire for Stock Alerts, Public Company News Alert
Global Pain Management Devices Market Could Exceed $9 Billion By 2026
From PR Newswire
BTG Specialty Pharmaceuticals announces the European Medicines Agency has accepted for review a marketing authorisation application for Voraxaze®
From PR Newswire
November 6th Options Now Available For Boston Scientific (BSX)
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.